Trachoma - a bacterial infection that affects the eyes - is one of the oldest known infectious diseases in human history. Despite being easily preventable and treatable, trachoma still remains a significant public health concern, especially in developing countries where sanitation facilities are poor. As medical professionals, understanding trachoma and its causes is essential to effectively diagnose and treat this condition. In this comprehensive guide, we'll explore everything you need to know about trachoma: from its symptoms to its causes and treatment options. So let's dive in!
Trachoma is a bacterial infection that primarily affects the eyes, and it's caused by repeated exposure to bacteria called Chlamydia trachomatis. The symptoms of trachoma usually take between five to twelve days after exposure before they begin to appear.
In its early stages, trachoma may not present any symptoms at all. However, as the condition progresses, you may experience itching or irritation in your eyes which can lead to swelling of the eyelids and discharge from the eye.
The inflammation caused by trachoma can also cause scarring on the inner surface of your eyelid that leads to entropion - a condition where your eyelashes grow inward towards your eyeball instead of outward. This can result in further irritation and damage to your cornea leading to loss of vision if left untreated.
Remember: prevention is always better than cure when it comes to infectious diseases like Trachoma!
Trachoma is an infectious eye disease caused by the bacterium Chlamydia trachomatis. This bacterium is transmitted through contact with hands, towels or clothing of infected individuals, and flies that have come into contact with infected discharge from the eyes or nose.
The risk factors for trachoma include poor sanitation, crowded living conditions, and lack of access to clean water. The disease tends to affect young children who are more susceptible to infection due to their underdeveloped immune systems.
Repeated infections can lead to scarring on the inner surface of the eyelid which can cause them to turn inwards towards the eyeball and scratch it. In severe cases, this can lead to blindness.
Trachoma is prevalent in areas where poverty is high and access to healthcare is limited. It affects millions of people around the world but can be prevented through proper hygiene practices such as handwashing, facial cleanliness, and environmental improvements like safe water supply and improved sanitation facilities.
Trachoma is a bacterial infection that can cause blindness if left untreated. Therefore, prompt treatment is crucial to prevent permanent damage to the eyes and vision loss.
The most common treatment for trachoma is antibiotics, which can be administered orally or topically. Antibiotics are effective in killing the bacteria responsible for trachoma and preventing its spread. Azithromycin is commonly used as an oral antibiotic, while tetracycline eye ointment is often prescribed as topical treatment.
Surgery may also be necessary in advanced cases of trachoma where scarring has caused eyelids to turn inward or outward, leading to further irritation and damage. Surgical intervention involves correcting the position of the eyelid through a procedure known as entropion surgery.
In addition to medical treatments, proper hygiene practices such as frequent washing of hands and face with soap and water can help prevent the spread of trachoma.
Trachoma is a serious eye infection that affects millions of people around the world, particularly in areas with poor sanitation and limited access to healthcare. It is caused by bacteria that spread through contact with infected individuals or contaminated objects.
Symptoms of trachoma include itching, watering eyes, and a thick discharge from the eyes. In severe cases, it can lead to blindness. The good news is that trachoma can be prevented and treated.
Prevention measures include improving hygiene practices such as face washing and reducing overcrowding in living spaces. Antibiotics are also used to treat active infections.
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation